SecBot SecBot
6-K ·Filed Apr 8, 2026

GLAXF

GSK plc
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago SEC0001654954-26-003331
Notable filing: 6-K
Actionable Insight • Neutral

This is a routine share buyback transaction under GSK's existing program. While it reduces share count slightly, the impact on EPS is minimal for a single day. Monitor the cumulative effect of the buyback program over time. No immediate trading opportunity is indicated.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d ⚠ clustered
GLAXF ▼ -8.06% at T+60d
NEUTRAL call -8.06% · α vs SPY -18.52% · entry $28.03 → $25.77
Entry = T+0 close
Apr 8, 2026
via day close
T+1d
0.00%
call 0.00% · α -0.57%
$28.03
settled 7mo ago
T+5d
+4.32%
call +4.32% · α +0.80%
$29.24
settled 7mo ago
T+20d
-10.77%
call -10.77% · α -19.32%
$25.01
settled 6mo ago
T+60d
-8.06%
call -8.06% · α -18.52%
$25.77
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

GSK plc repurchased 335,000 ordinary shares on April 7, 2026, at a volume-weighted average price of 2,113.08 GBp, as part of its ongoing buyback program. This transaction is routine under the company's existing share repurchase plan.

Key Facts

  • GSK repurchased 335,000 ordinary shares on April 7, 2026
  • Volume-weighted average price paid was 2,113.08 GBp per share
  • Lowest price paid was 2,084.00 GBp, highest was 2,134.00 GBp
  • Shares were purchased through BNP Paribas SA on multiple exchanges
  • Repurchased shares will be held as treasury shares

Financial Impact

The company spent approximately £708 million ($885 million) on this single day's repurchase based on the volume-weighted average price

shares outstandingtreasury sharescash position

Risk Factors

  • Dilution of shareholder value if buybacks continue at premium prices
  • Opportunity cost of using cash for buybacks versus R&D or dividends

Market Snapshot

Exchange
OTC
Sector
Pharmaceutical Preparations

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
6-K Filing (Primary)0001654954-26-003331
Document: 0001654954-26-003331-index-headers.html0001654954-26-003331
Document: 0001654954-26-003331-index.html0001654954-26-003331
Document: 0001654954-26-003331.txt0001654954-26-003331
51 reports for GLAXF
Performance horizon
46% Hit rate @ T+5 6 of 13 directional calls Went positive at some point 7 of 13 best @ T+20▲ +9.49%Jun 9, 2026
Filters
Rows
Reports for GLAXF — sortable, filterable
TypeNow
Jun 10, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$25.12 $25.25▲ +0.52%▼ −1.62%$26.12 (+3.98%)
Jun 9, 2026
19w ago
6-K
NEUTRAL ★ 1/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 9, 2026
19w ago
6-K
BULLISH ★ 7/10
$24.66 $25.50▲ +3.41%▲ +1.60%$26.12 (+5.92%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
Jun 1, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$24.25 $24.66▲ +1.69%▲ +4.44%$26.12 (+7.71%)
May 28, 2026
21w ago
6-K
BULLISH ★ 7/10
$24.58 $24.66▲ +0.33%▲ +0.01%$26.12 (+6.27%)
May 27, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.57 $23.94▼ −6.37%▼ −7.58%$26.12 (+2.15%)
May 26, 2026
21w ago
6-K
NEUTRAL ★ 1/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 26, 2026
21w ago
6-K
NEUTRAL ★ 2/10
$25.50 $24.25▼ −4.90%▼ −5.99%$26.12 (+2.43%)
May 22, 2026
22w ago
6-K
NEUTRAL ★ 2/10
$26.00 $24.25▼ −6.73%▼ −8.39%$26.12 (+0.46%)
Showing 10 of 51

US Market Status

Market Closed — Opens in 4h 55m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 8, 2026